drugset / Trial / NCT04458636
Stratified TreAtment to Reduce Risk in COPD
Phase 4
Completed
203 enrolled
University of Oxford
National Institute for Health Research, United Kingdom · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the efficacy of blood-eosinophil directed corticosteroid therapy using near-patient testing, compared to current standard practice during an exacerbation of COPD in a multi-centre randomised placebo controlled trial.
Timeline
- Start
- 2017-11-02
- Primary completion
- 2020-02-28
- Completion
- 2020-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prednisolone | Other / unclassified | 30 mg | Oral |